LINC00641 and non-small cell lung carcinoma: Recent reports have revealed that the expression of LINC00641 was increased and involved in the tumorigenicity of bladder cancer, non-small-cell lung cancer (NSCLC) and acute myeloid leukemia (AML) [18–20].